President & CEO of Ultragenyx Pharmaceutical Inc (30-Year Financial, Insider Trades) Emil D Kakkis (insider trades) sold 30,000 shares of RARE on 01/04/2021 at an average price of $136.9 a share. The total sale was $4.1 million.
Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases. Ultragenyx Pharmaceutical Inc has a market cap of $9.05 billion; its shares were traded at around $136.750000 with and P/S ratio of 38.05.
CEO Recent Trades:
- President & CEO Emil D Kakkis sold 30,000 shares of RARE stock on 01/04/2021 at the average price of $136.9. The price of the stock has decreased by 0.11% since.
For the complete insider trading history of RARE, click here
.This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
